Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Inmune Bio, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsMar-31-20Dec-31-19Sep-30-19Jun-30-19Mar-31-19Dec-31-18Sep-30-18Jun-30-18
   8-K10-K10-Q10-Q10-Q10-K10-Q10-Q
Revenues  2.32.30.00.00.00.00.00.0
Cost of goods sold  -2.0-2.0-2.0-2.00.00.01.11.1
Gross profit  4.34.32.02.00.00.0-1.1-1.1
            Gross margin  184.5%184.5%      
Selling, general and administrative   [+]6.46.96.35.39.510.49.79.0
Research and development  3.12.42.62.02.02.01.30.7
Other operating expenses   2.8 0.4    
EBIT   [+]-7.9-7.8-7.3-5.8-11.5-12.4-10.8-9.6
            EBIT margin  -340.3%-332.5%      
Interest income  0.10.10.10.0    
Other income (expense), net   [+]    0.0   
Pre-tax income  -7.8-7.7-7.2-5.7-11.5-12.4-11.0-9.7
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -7.8-7.7-7.2-5.7-11.5-12.4-11.0-9.7
            Net margin  -336.5%-329.2%      
   
Basic EPS   [+]($0.75)($0.76)($0.74)($0.62)($1.30)($1.44)($1.35)($1.31)
Diluted EPS   [+]($0.75)($0.76)($0.74)($0.62)($1.30)($1.44)($1.35)($1.31)
   
Shares outstanding (basic)   [+]10.510.19.79.28.98.78.17.4
Shares outstanding (diluted)   [+]10.510.19.79.28.98.78.17.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy